Cannabis and Psychosis: An Overview of The Relationship
Revista Portuguesa de Psiquiatria e Saúde Mental September 30, 2023 Rodrigo Saraiva, Ricardo Coentre
N/A
Revista Portuguesa de Psiquiatria e Saúde Mental
ISSN 2184-5417
5 papers in the library · publishing 2021-2023
Papers
Mindfulness as Adjuvant Treatment for Obsessive‐Compulsive Disorder: An Integrative Review
Revista Portuguesa de Psiquiatria e Saúde Mental June 16, 2023 Lucas Cruz Torres, Francisco Filho, Tainah Pereira et al.
Obsessive‐compulsive disorder is characterized by the presence of obsessions and/or compulsions. Standard treatment, although effective in improving symptoms, in more severe cases may not be sufficient. The objective of this study was to identify in the literature data on the effectiveness of Mindfulness as a complementary treatment in reducing symptoms in patients with obsessive‐compulsive...
DOI: 10.51338/rppsm.290 (opens in new tab)
Full text (opens in new tab)
Mindfulness
Cognitive behavioral therapy
Obsessive‐compulsive disorder/therapy
Treatment outcome
Psicoterapia Assistida por MDMA: um Novo Paradigma no Tratamento da Perturbação de Stress Pós‐Traumático Resistente?
Revista Portuguesa de Psiquiatria e Saúde Mental November 27, 2022 Pedro Mota, Joana Proença Becker, Manuel João Quartilho
A perturbação de stress pós‐traumático (PSPT) é uma doença psiquiátrica comum, geralmente crónica, com severas implicações na qualidade de vida da pessoa afetada e da sua família, e que tem vindo a apresentar um crescente reconhecimento enquanto problema de Saúde Pública. Nas últimas duas décadas, estudos clínicos com 3,4‐metilenodioximetanfetamina (MDMA) têm vindo a demonstrar...
Treating Major Depression Disorder with Psychedelics: A Potential Therapeutic Application for Psilocybin?
Revista Portuguesa de Psiquiatria e Saúde Mental September 8, 2021 Gonçalo Cotovio, Ana Maia, Ana Velosa et al.
.
DOI: 10.51338/rppsm.2021.v7.i3.241 (opens in new tab)
Psilocybin
Depression economics
Hallucinogen
Psychotherapist
Esketamine in Treatment Resistant Depression: The Way to Remission
Revista Portuguesa de Psiquiatria e Saúde Mental March 5, 2021 João Facucho-Oliveira, Daniel Esteves-Sousa, Bruno Prates et al.
Major depressive disorder affects an estimate of 5% of the population with nearly 1‑third of patients failing to achieve remission with conventional pharmacological treatment. Esketamine, a novel rapid‑acting antidepressant, with a noncompetitive antagonism on N‑methyl‑D‑Aspartate receptor, have been recently approved by Food and Drug Administration (FDA) and European Medicines Agency (EMA) for...